Alpha Amylase Sirop for Baking: Dosage, pH, Temperature, and Troubleshooting

In B2B bakery procurement, the phrase “alpha amylase sirop” or “sirop alpha amylase” is often used to describe a liquid alpha amylase enzyme preparation supplied for dosing into flour, sponge, brew, or dough systems. It should not be confused with consumer health products or diagnostic alpha amylase werte. For baking, the relevant question is process performance: how the enzyme hydrolyzes damaged starch into fermentable sugars and dextrins during mixing, fermentation, proofing, and early baking. The result can affect yeast activity, crust color, loaf volume, softness, and shelf-life perception. The same label name does not guarantee equivalent performance. Activity units, production organism, carrier system, concentration, and side activities all matter. Buyers should request a current TDS, COA, and SDS, then confirm performance through pilot bakes on the target flour and recipe.

Clarify whether the product is liquid, powder, or granulated. • Confirm declared enzyme activity and test method. • Check compatibility with flour improvers, emulsifiers, yeast, and oxidants. • Avoid using medical or supplement dosage information for bakery processes.

Most bakery doughs operate around pH 5.0–6.0, which is suitable for many fungal alpha-amylase preparations. Some bacterial amylase products are designed for higher temperature stability and may remain active longer during the bake, so they require careful selection and validation to avoid gummy crumb. Mixing temperatures are commonly held near 24–28°C for pan bread, while proofing may run around 30–38°C depending on yeast system and product style. Enzyme activity increases as dough warms, then decreases as proteins denature in the oven. Many fungal alpha-amylases lose activity as crumb temperature moves through roughly 70–85°C; more thermostable bacterial versions may persist longer. The right choice depends on the desired sugar release window. When troubleshooting, measure actual dough pH and internal temperature rather than relying on setpoints, because fermentation rate, acidulants, sourdough, and retarded dough schedules can shift performance.

Record dough pH at make-up and after proof. • Track dough temperature after mixing, before proof, and before baking. • Use internal crumb temperature data to understand inactivation timing. • Avoid switching to bacterial amylase without a gummy-crumb risk trial.

An alpha amylase supplier should support more than a price quote. For each candidate alpha-amylase, request the TDS for activity, recommended pH and temperature range, dosage guidance, storage conditions, shelf life, and handling notes. The COA should confirm lot-specific activity and key quality checks, while the SDS should address safe industrial handling, dust or aerosol risk, personal protective equipment, and spill management. Also request allergen, food-grade suitability, country-of-origin, and carrier information relevant to your market. Cost-in-use should include dose per tonne flour, activity retention during storage, dosing accuracy, waste, trial support, and impact on scrap or customer complaints. A lower-cost product can be more expensive if it requires higher dosage or causes process variability. Before approval, complete pilot validation, one plant-scale run, and a supplier change-control review.

Compare products on cost per functional bake result, not cost per kilogram. • Confirm minimum order quantity, lead time, and packaging fit for your plant. • Require lot traceability and notification of material or process changes. • Store liquids and powders according to the supplier’s TDS conditions.

No. In an industrial baking context, alpha amylase sirop usually refers to a liquid alpha amylase enzyme preparation used as a processing aid or ingredient system component. It is evaluated by activity units, dose on flour, pH and temperature behavior, and bake performance. Medical uses, diagnostic alpha amylase werte, and consumer syrup dosing are outside the scope of bakery process design.

Begin with the supplier’s recommended range, then run a small matrix around it. A common screening approach is three dose levels plus an untreated control, using the same flour, water absorption, yeast level, proof time, and bake profile. Measure loaf volume, crust color, crumb texture, stickiness, and slicing after full cooling. Final dosage should be based on activity units and repeatable plant results.

Bacterial amylase can be useful where greater heat tolerance or a longer starch-hydrolysis window is desired, but it can also increase the risk of excessive dextrin formation and gummy crumb if not controlled. It should be trialed against a fungal alpha amylase enzyme under the real bake profile. Confirm pH range, inactivation behavior, and dose sensitivity before approving it for production.

At minimum, request a technical data sheet, certificate of analysis, and safety data sheet for the exact product and lot. The TDS should state activity, dosage guidance, pH and temperature range, storage, shelf life, and application notes. The COA should verify lot-specific activity. The SDS should support safe handling, including enzyme dust or aerosol exposure controls for industrial personnel.

Common causes include a new flour crop, lower Falling Number, higher damaged starch, longer proof, warmer dough, delayed baking, or a change in oven profile. A more active enzyme lot or dosing pump drift can also contribute. Check flour QC, enzyme COA, actual pump output, dough pH, internal crumb temperature, and cooling time. Reduce dose only after confirming the process change.